(0 items)
Small Medium Large | Print-Friendly Version of this Page  | Email this Page to a Friend
Skip Navigation Links
Blood FAQ
Patient Blood Management
Facts About Cellular Therapies
AABB Center for Cellular Therapies
Circulars of Information
Donor History Questionnaires
Emerging Infectious Disease Agents
TRANSFUSION August 2009 Supplement Appendices
TRANSFUSION August 2009 Supplement Fact Sheets
Fact Sheets Created or Updated Post Publication of the TRANSFUSION August 2009 Supplement
Pathogen Reduction Systems – Updates to Information Provided in the TRANSFUSION August 2009 Supplement
Acknowledgments
NBCUS
Highlights of Transfusion Medicine History
Related Links

Acknowledgments 

A sincere thank you is extended to the AABB TTD Emerging Infectious Diseases subgroup and contributing writers who updated information originally published in the August 2009 Transfusion Supplement and developed additional EID Fact Sheets.

AABB TTD EID subgroup:

Celso Bianco, MD, Scientific Consultant in Transfusion Medicine, Bethesda, MD
Michael P. Busch, MD, PhD, Blood Systems Research Institute, University of California, San Francisco, CA
Larisa Cervenakova, PhD, American Red Cross Blood Services, Rockville, MD
Roger Y. Dodd, PhD, American Red Cross Blood Services, Rockville, MD
Diane Gubernot, MPH, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER, FDA, Rockville, MD
F. Blaine Hollinger, MD, Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, TX
Louis M. Katz, MD, America’s Blood Centers, Washington, DC
Steven Kleinman, MD, University of British Columbia, Vancouver, BC, Canada
Susan L. Stramer, PhD, American Red Cross Blood Services, Gaithersburg, MD

Contributing writers for fact sheets:

Charles H. Calisher, PhD, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and    Biomedical Sciences, Colorado State University, Fort Collins, CO
Eric Delwart, PhD, Blood Systems Research Institute, University of California, San Francisco, CA
Philip Kiely, BSc(Hons), Australian Red Cross Blood Service, West Melbourne, Australia
David A. Leiby, PhD, American Red Cross Blood Services, Rockville, MD
Jeanne V. Linden, MD, MPH, New York State Department of Health, Albany, NY
Robert Massung, PhD, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Hans Zaaijer, MD, PhD, Department of Blood-borne Infections, Sanquin, Amsterdam, The Netherlands

Contributing writers for pathogen reduction technology updates:

Ray Goodrich PhD, Chief Science Officer, CaridianBCT Biotechnologies, Lakewood, CO
Peyton S. Metzel, PhD, formerly of Fenwal, Inc., Lake Zurich, IL
Stefan Reichenberg, PhD, Scientific Marketing Manager, Macopharma, Langen, Germany
Adonis Stassinopoulos, PhD, VP Scientific Affairs, Cerus Corporation, Concord, CA
Lynette Sawyer, DPH, Director, Microbiology and Hematology, Cerus Corporation, Concord, CA

Return to Emerging Infectious Disease Agents

Home  |  Site Map  | AABB © 2014. All rights reserved. |  Privacy Statement  |  Terms of Use